Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biobank for Validating Liquid Biopsy in Predicting the Prognosis of Superficial Colonic Lesions

NCT07319104 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT07319104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07319104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biobank for Validating Liquid Biopsy in Predicting the Prognosis of Superficial Colonic Lesions
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Not yet recruiting
Start date
June 15, 2026
Completion date
December 15, 2031
Enrollment
1,000 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the colon, colorectal neoplasms, precancerous conditions